Congenital adrenal hyperplasia due to 21-hydroxylase deficiency A paradigm for prenatal diagnosis and treatment

被引:22
作者
Nimkarn, Saroj [1 ]
New, Maria I. [1 ]
机构
[1] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA
来源
SKELETAL BIOLOGY AND MEDICINE | 2010年 / 1192卷
关键词
21-hydroxylase deficiency; congenital adrenal hyperplasia; prenatal care; steroid hydroxylases; prenatal diagnosis; MATERNAL PLASMA; GENDER CHANGE; FETAL DNA; CHILDREN; GENE; UPDATE; GIRLS;
D O I
10.1111/j.1749-6632.2009.05225.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
21-Hydroxylase deficiency is the most common cause of congenital adrenal hyperplasia (CAH), an inherited disorder of steroidogenesis. In its severe form, CAH causes genital ambiguity in females. Molecular genetic analysis of fetal DNA obtained by amniocentesis or chorionic villus sampling is used to diagnose steroid 21-OHD deficiency in utero. Large ongoing studies show that appropriate prenatal treatment of pregnant mothers with dexamethasone is effective and safe for both the fetus and the mother. It reduces ambiguous genitalia in the female affected fetus and thus avoids unnecessary genitoplasty in the newborn female.
引用
收藏
页码:5 / 11
页数:7
相关论文
共 50 条
  • [21] Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Felix G. Riepe
    Wolfgang G. Sippell
    Reviews in Endocrine and Metabolic Disorders, 2007, 8 : 349 - 363
  • [22] Sequential Use of Hydrocortisone and Dexamethasone in Prenatal Treatment of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
    Ucar, Ahmet
    Saka, Nurcin
    Bas, Firdevs
    Poyrazoglu, Sukran
    Bundak, Ruveyde
    Darendeliler, Feyza
    HORMONE RESEARCH IN PAEDIATRICS, 2013, 79 (05): : 323 - 324
  • [23] Treatment of adult men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Knape, P.
    Reisch, N.
    Doerr, H.-G.
    Reincke, M.
    Quinkler, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (19) : 1025 - 1029
  • [24] Update on the prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
    Motaghedi, R
    Betensky, BP
    Slowinska, B
    Cerame, B
    Cabrera, M
    New, MI
    Wilson, RC
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2005, 18 (02) : 133 - 142
  • [25] Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Forest, MG
    HUMAN REPRODUCTION UPDATE, 2004, 10 (06) : 469 - 485
  • [26] Pitfall of newborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Rohrer, TR
    Gassmann, KF
    Pavel, ME
    Dörr, HG
    BIOLOGY OF THE NEONATE, 2003, 83 (01): : 65 - 68
  • [27] Prenatal diagnosis and treatment of congenital adrenal hyperplasia
    Nimkarn, Saroj
    New, Maria I.
    HORMONE RESEARCH, 2007, 67 (02) : 53 - 60
  • [28] Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - the adult woman
    Hagenfeldt, KB
    GROWTH HORMONE & IGF RESEARCH, 2004, 14 : S67 - S71
  • [29] Health Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
    Reisch, Nicole
    Arlt, Wiebke
    Krone, Nils
    HORMONE RESEARCH IN PAEDIATRICS, 2011, 76 (02): : 73 - 85
  • [30] Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency through molecular genetic analysis of the CYP21A2 gene
    Yoon, Ji-Hee
    Hwang, Soojin
    Kim, Ja Hye
    Kim, Gu-Hwan
    Yoo, Han-Wook
    Choi, Jin-Ho
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2024, 29 (01) : 54 - 59